![]() Pliant Therapeutics Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases. | Angion Biomedica Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury. | ![]() Kadmon Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C. | |||
Founding Date | Founding Date 2016 | Founding Date 2012 | Founding Date 1998 | Founding Date 2010 | Founding Date 1999 |
Type | Type Private | Type Private | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Nijmegen, NL HQ | Locations San Francisco, US HQ Uniondale, US | Locations New York, US HQ Cambridge, US South Brunswick Township, US Warrendale, US | Locations Mechelen, BE HQ Romainville, FR Leiden, NL Basel, CH Waltham, US |
Employees | Employees 1519% decrease | Employees 1 | Employees 205% increase | Employees 44 | Employees 70437% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $2.3m (FY, 2022) | Revenue (est.) $8.3m (FY, 2020) | Revenue (est.) €1.1b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($38.8m) (FY, 2022) | Net income ($108.9m) (FY, 2020) | Net income €320.9m (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 62m (almost 8 years ago) | Latest funding round $ 30m (almost 8 years ago) | Latest funding round $ 15.4m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 107m | Total funding raised $ 37m | Total funding raised $ 19.7m | Total funding raised $ 21.3m | Total funding raised $ 3.7m |
Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury.
View company
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
View company